Biotechnology

By Alexa Mikhail and Beth GreenfieldMarch 24, 2025

By Michelle WernerMarch 10, 2025

LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025

HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025

HealthArnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By Lindsey LeakeNovember 13, 2024

TechMeta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By Sharon GoldmanJune 25, 2024

CommentaryI’ve been practicing medicine at a renowned institution for 40 years. Society isn’t ready for us to reverse the aging process across an entire population
By Joel GeidermanJune 20, 2024

LifeA 45-year-old tech CEO is spending millions a year to be 18 again—even though his doctor admits the results are minimal
By Alexa MikhailJanuary 26, 2023

By Tristan BoveSeptember 12, 2022

NewslettersAt financial software giant Intuit, A.I. is becoming ‘foundational’ to how the company operates
By Jeremy KahnAugust 26, 2022

NewslettersA.I. is rapidly transforming biological research—with big implications for everything from drug discovery to agriculture to sustainability
By Jeremy KahnJuly 28, 2022
Most Popular





